Trading Update & Investor Presentation

RNS Number : 0102H
Deepverge PLC
01 December 2020
 

1 December 2020

 

DeepVerge PLC

 

("DeepVerge" or "the Company")

 

Trading Update & Investor Presentation

 

DeepVerge (LSE:DVRG.L), the scientific research and AI-as-a-Service company, is pleased to announce that guidance of £4m revenues for the Company for year ending 31 December 2020 remains on track  and amalgamated revenues which include Modern Water plc, acquired on 9 November, 2020, are expected to be well above £4m.

Gerry Brandon, Chief Executive Officer, will be presenting at an investor webinar being hosted jointly by Turner Pope Investments (TPI) Ltd and Vox Markets.

The event will be held later today, 1 December 2020 at 2pm. Please register your interest at  https://voxmarkets.brand.live/c/deepverge-webinar

A copy of the webinar presentation will be posted on the DeepVerge website contemporaneously.

 

Gerard Brandon, CEO of DeepVerge, Commented:

"The presentation will reiterate the guidance for 2020, provide an update on sales, marketing, supply chain management of products and services under development for a post-COVID world and I look forward to the opportunities that are ahead for the enlarged Group."

 

For further information please contact:

DeepVerge plc

Gerard Brandon, CEO

 

+44 (0) 7340 055 648

SPARK Advisory Partners Limited

(Nominated Adviser)

 

Neil Baldwin/Andrew Emmott

+44 (0) 113 370 8974

Turner Pope Investments (TPI) Limited (Broker)

Andy Thacker/Zoe Alexander

+44 (0) 20 3657 0050

 

About DeepVerge plc (www.deepverge.com)

DeepVerge is a scientific research and AI-as-a-Service company focused on production and analysis of bacteria, virus and toxins utilising artificial intelligent data analytics in regulatory technology, from scientifically proving the impact of skincare product claims on skin microbiome for top 20 global cosmetic company clients to remotely detecting water contamination in real-time.

 

In November 2020, DeepVerge acquired Modern Water who developed and commercialised a cutting-edge technology, focused on monitoring of contaminated water and decontamination of wastewater, making recycling of water more efficient. Six countries across the world have legislated that Modern Water monitoring test systems are written into their environmental protection legislation.  The Company is in final trials for its real-time contamination product, Microtox PD, for the identification of COVID-19 hotspots and other pathogens.

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
TSTURUWRROUAOAA
UK 100

Latest directors dealings